| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $24.6M | +29.2% |
| SG&A Expense | $9.8M | +28.3% |
| Operating Income | -$34.4M | -28.9% |
| Pre-tax Income | -$32.7M | -34.1% |
| Income Tax | $28K | -6.7% |
| Net Income | -$32.8M | -34.0% |
| EPS (Basic) | -$0.70 | -16.7% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $15.6M | +417.3% |
| Short-term Investments | $44.2M | +7.6% |
| Accounts Receivable | $258K | +9.3% |
| Current Assets | $60.6M | +35.9% |
| Total Assets | $61.4M | +32.4% |
| Current Liabilities | $5.1M | -4.8% |
| Stockholders' Equity | $56.1M | +37.8% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$29.1M | -31.6% |
| Capital Expenditures | $40K | +60.0% |
| Investing Cash Flow | -$2.2M | -125.6% |
| Financing Cash Flow | $43.9M | +265.8% |
| Free Cash Flow | -$29.1M | -31.7% |